Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | PHD-finger family protein | 0.0029 | 0.0289 | 0.1185 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0341 | 0.3907 | 0.6218 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0437 | 0.0437 |
Schistosoma mansoni | bromodomain containing protein | 0.0005 | 0.0012 | 0.0019 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0031 | 0.0311 | 0.0311 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0179 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0179 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0179 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0501 | 0.0798 |
Loa Loa (eye worm) | hypothetical protein | 0.0005 | 0.0012 | 0.005 |
Echinococcus multilocularis | geminin | 0.0546 | 0.6282 | 0.6282 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0437 | 0.0696 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0501 | 0.0798 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.003 | 0.0298 | 0.0475 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0179 | 0.5761 |
Trichomonas vaginalis | set domain proteins, putative | 0.0244 | 0.2786 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.0184 | 0.0293 |
Schistosoma mansoni | hypothetical protein | 0.0546 | 0.6282 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0179 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0546 | 0.6282 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0179 | 0.0286 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0232 | 0.0369 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0069 | 0.0757 | 0.0757 |
Onchocerca volvulus | 0.0244 | 0.2786 | 1 | |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0069 | 0.0757 | 0.1205 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0501 | 0.0798 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0051 | 0.0541 | 0.086 |
Echinococcus granulosus | zinc finger protein | 0.0023 | 0.0218 | 0.0346 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0501 | 0.0501 |
Echinococcus granulosus | cyclin dependent kinase 6 | 0.0341 | 0.3907 | 0.6218 |
Echinococcus multilocularis | zinc finger protein | 0.0023 | 0.0218 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.047 | 0.1925 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.016 | 0.0255 |
Loa Loa (eye worm) | bromodomain containing protein | 0.002 | 0.0192 | 0.0786 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0179 | 0.0286 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0026 | 0.0258 | 0.041 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0179 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0051 | 0.0541 | 0.086 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0031 | 0.0311 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0024 | 0.0232 | 0.095 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0179 | 0.0735 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0502 | 0.2056 |
Brugia malayi | Pre-SET motif family protein | 0.0215 | 0.2442 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0051 | 0.0541 | 0.086 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0.016 | 0.893 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0179 | 0.5 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0179 | 0.5761 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0026 | 0.0258 | 0.041 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.0501 | 0.2053 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0215 | 0.2442 | 1 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0026 | 0.0258 | 0.0258 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0541 | 0.2214 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.002 | 0.0184 | 0.0293 |
Onchocerca volvulus | 0.0031 | 0.0311 | 0.1118 | |
Echinococcus granulosus | geminin | 0.0546 | 0.6282 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0311 | 0.0496 |
Leishmania major | hypothetical protein, conserved | 0.0018 | 0.016 | 0.893 |
Schistosoma mansoni | zinc finger protein | 0.0023 | 0.0218 | 0.0346 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0179 | 0.0735 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0051 | 0.0541 | 0.0541 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0528 | 0.2161 |
Plasmodium vivax | SET domain protein, putative | 0.0031 | 0.0311 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0501 | 0.0798 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0179 | 1 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0.016 | 0.893 |
Echinococcus multilocularis | cyclin dependent kinase 6 | 0.0341 | 0.3907 | 0.3907 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.0179 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.0905 | 0.3706 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0179 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0179 | 0.0179 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.0184 | 0.0293 |
Brugia malayi | Pre-SET motif family protein | 0.0031 | 0.0311 | 0.1275 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.0501 | 0.2053 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0179 | 0.0286 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0179 | 0.0644 |
Schistosoma mansoni | bromodomain containing protein | 0.0073 | 0.0805 | 0.1281 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0501 | 0.0501 |
Trypanosoma brucei | ISWI complex protein | 0.0018 | 0.016 | 0.893 |
Brugia malayi | Bromodomain containing protein | 0.0087 | 0.0962 | 0.3941 |
Brugia malayi | Bromodomain containing protein | 0.0044 | 0.0469 | 0.1922 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0179 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0501 | 0.0798 |
Schistosoma mansoni | zinc finger protein | 0.0018 | 0.016 | 0.0255 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0031 | 0.0311 | 0.0496 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0179 | 1 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.002 | 0.0184 | 0.0184 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0179 | 0.0644 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 34.93 uM | Cytotoxicity against human A549 cells after 48 hrs by MTT assay | ChEMBL. | 22472043 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.